MetLife Expands Usage-Based Auto Insurance Program with New App to Help Drivers Stay Safer and Lower Their Rates
The My Journey program app automatically tracks key driving behaviors, including total miles driven, time of day, road type and conditions, hard braking and harsh acceleration, and phone-based distracted driving, in order to arrive at a score for each trip. The app does so by leveraging the sensors that are built into smartphones to continuously analyze data as the car is in motion. The app calculates and immediately displays an overall score for each trip from 1-100, with 100 being the safest possible trip. A cumulative safety score is built as time goes by.
“Today’s drivers face more distractions on the road than ever, which increases the risk of driving and puts upward pressure on car insurance rates,” noted
Through the app, drivers can get a good idea of how they drive, as well as when and by what they are being distracted, so they can alter their behavior and become safer drivers. Drivers who enroll in the program immediately get ten percent off MetLife Auto & Home’s standard rates. After drivers spend six months in the program, MetLife Auto & Home will have enough driving data calculate a discount , and careful behavior will be rewarded with rates up to 30 percent off at the following renewal. Rates are not being increased as a result of information gathered, and the My Journey mobile app is free to those who enroll in the program.
“Our technology gives MetLife Auto & Home customers feedback that helps them become better drivers and makes the roads safer for all,” said
The smartphone-enabled My Journey program is now available in
About MetLife Auto & Home:
MetLife Auto & Home is one of the nation’s leading personal lines insurance groups, insuring more than 4 million autos and homes, and is affiliated with MetLife. For more information, visit www.metlife.com.
About MetLife
About TrueMotion
Headquartered in
View source version on businesswire.com: http://www.businesswire.com/news/home/20170518005689/en/
[email protected]
Source:



FDA’s Pazdur Outlines How Oncology Center of Excellence Will Promote Collaboration in AJMC®’s Evidence-Based Oncology™
Advisor News
- NAIFA: Financial professionals are essential to the success of Trump Accounts
- Changes, personalization impacting retirement plans for 2026
- Study asks: How do different generations approach retirement?
- LTC: A critical component of retirement planning
- Middle-class households face worsening cost pressures
More Advisor NewsAnnuity News
- Trademark Application for “INSPIRING YOUR FINANCIAL FUTURE” Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
- Jackson Financial ramps up reinsurance strategy to grow annuity sales
- Insurer to cut dozens of jobs after making splashy CT relocation
- AM Best Comments on Credit Ratings of Teachers Insurance and Annuity Association of America Following Agreement to Acquire Schroders, plc.
- Crypto meets annuities: what to know about bitcoin-linked FIAs
More Annuity NewsHealth/Employee Benefits News
- Validation of the French Versions of the PHQ-4 Anxiety and Depression Scale and the PC-PTSD-5 Post-Traumatic Stress Disorder Screening Scale: Mental Health Diseases and Conditions – Anxiety Disorders
- EmblemHealth will pay $2.5M after investigation reveals 'ghost network' of providers
- Researchers from California Polytechnic State University Report on Findings in COVID-19 (Exploring the Role of Race/Ethnicity, Metropolitan Status, and Health Insurance in Long COVID Among U.S. Adults): Coronavirus – COVID-19
- Former NFL player convicted in nearly $200M Medicare fraud scheme
- Senior Health Insurance in Florida Adapts to 2026 Care Costs
More Health/Employee Benefits NewsLife Insurance News